FDA May Investigate DNA Contamination in COVID Shots
The U.S. Food and Drug Administration (FDA) is considering investigating potential DNA contamination in mRNA COVID-19 shots. Tracy Beth Hoeg, MD, senior adviser to FDA commissioner Marty Makary, MD, MPH, confirmed that the investigation is “something that’s being discussed.”1 Retsef Levi, PhD, chair of the U.S. Centers for Disease and Prevention’s (CDC) COVID-19 immunization workgroup, […]
Higher Cancer Rates Found After Receipt of COVID-19 Shots
A new, peer-reviewed study by researchers in South Korea has found that people who received COVID-19 shots showed significantly higher rates of developing several cancers—including thyroid, stomach, colon, lung, breast, and prostate—compared to unvaccinated individuals. The research, published on Sept. 26, 2025 in the journal Biomarker Research, was authored by South Korean medics in orthopedic […]
Cancer Treatments Using mRNA Technology Targeted as COVID Shots Sales Decline
BioNTech SE and Moderna, Inc., two leading pharmaceutical companies that developed the mRNA COVID-19 biological, are facing new financial and regulatory challenges as demand for COVID booster shots continues to fall and U.S. health policy changes reshape the vaccine market.1 Moderna cut its 2025 sales forecast to between $1.5 billion and $2.2 billion, down as […]
FDA to Release Report on Child Deaths After COVID Shots
On Sept. 4, 2025, the commissioner of the U.S. Food and Drug Administration (FDA), Marty Makary, MD, announced the agency will release a detailed report investigating deaths among children following receipt of COVID-19 shots.1 2 Dr. Makary stated that officials have begun carrying out an “intensive investigation” into reports submitted to the Vaccine Adverse Event […]
FDA Revokes EUA Status for COVID-19 Shots
The U.S. Department of Health and Human Services (DHHS) has revoked emergency use authorization (EUA) for the COVID-19 shots. The federal government had relied on the EUA status to justify release of the COVID-19 biologicals in December 2020 for public distribution without full licensure by the FDA.1 On Aug. 27, 2025, DHHS Secretary Robert F. […]
DHHS Cancels $500 Million in Funding for mRNA Vaccine Development
Department of Health and Human Services (DHHS) Secretary Robert F. Kennedy, Jr. announced on Aug. 5, 2025 that DHHS is canceling $500 million in vaccine development projects, specifically those using mRNA technology. The decision affects 22 projects, including contracts with Emory University and Tiba Biotech. Proposals from Pfizer, Sanofi Pasteur, CSL Seqirus, Gritstone, and others […]